Diaper Rash Clinical Trials

• Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash
  ClinicalTrials.gov Identifier: NCT00219466 - Completed
  Diaper Dermatitis
  
• Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
  ClinicalTrials.gov Identifier: NCT00473083 - Not yet recruiting
  Rash
  
• Investigation of Southern Tick-Associated Rash Illness (STARI)
  ClinicalTrials.gov Identifier: NCT00358761 - Recruiting
  Southern Tick-Associated Rash Illness
  
• Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
  ClinicalTrials.gov Identifier: NCT00362986 - Active, not recruiting
  Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
  
• STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-Line Irinotecan Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00332163 - Active, not recruiting
  Metastatic Colorectal Cancer; Skin Rash; Skin Toxicities; Colon Cancer; Colorectal Cancer
  
• Regenecare® Wound Gel in Treating Rash in Patients Receiving Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00466427 - Recruiting
  Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
  
• Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00498992 - Recruiting
  Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
  
• A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash
  ClinicalTrials.gov Identifier: NCT00343187 - Terminated
  Rash; Non-Small-Cell Lung Cancer
  
• A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00531934 - Recruiting
  Non-Small Cell Lung Cancer
  
• Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
  ClinicalTrials.gov Identifier: NCT00091247 - Recruiting
  unspecified adult solid tumor, protocol specific